Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2022
Historique:
received: 16 02 2021
accepted: 22 06 2021
pubmed: 28 9 2021
medline: 4 3 2022
entrez: 27 9 2021
Statut: ppublish

Résumé

This study aimed to assess whether enhanced recovery after surgery (ERAS) improves, at different time points, postoperative complications in patients undergoing radical cystectomy. We performed a retrospective monocentric study using prospectively maintained databases including all patients treated by radical cystectomy between January 2015 and July 2019. An ERAS protocol was applied in all patients from February 2018. We analyzed and compared between non-ERAS and ERAS groups early and 90-day postoperative complications and 90-day readmission. ERAS was analyzed to know its implication in fast recovery improvement over time. A total of 150 patients underwent radical cystectomy, 74 without ERAS and 76 with ERAS protocol. ERAS decreased significantly early (p = 0.039) and 90-day (0.012) postoperative complications. In multivariate analysis, ERAS was an independent factor associated with less early (OR: 0.48, 95% CI: 0.25-0.96; p = 0.37) and 90-day (OR: 0.31, 95% CI: 0.14-0.68; p = 0.004) postoperative complications. There was no significant difference between groups for 90-day readmission (p = 0.349). Mean length of stay did not differ significantly between ERAS and non-ERAS groups (12.7 ± 6.2 and 13.1 ± 5.7 days, respectively; p = 0.743). Our study shows that ERAS has an early positive impact that lasts over time on postoperative complications. ERAS implementation has decreased early and 90-day postoperative complications without increasing 90-day readmission. In our cohort, length of stay was not improved with ERAS protocol.

Identifiants

pubmed: 34569540
pii: 000518163
doi: 10.1159/000518163
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-179

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

François Lannes (F)

Department of Oncologic Surgery 2, Institute Paoli Calmettes, Marseille, France.

Jochen Walz (J)

Department of Oncologic Surgery 2, Institute Paoli Calmettes, Marseille, France.

Thomas Maubon (T)

Department of Oncologic Surgery 2, Institute Paoli Calmettes, Marseille, France.

Stanislas Rybikowski (S)

Department of Oncologic Surgery 2, Institute Paoli Calmettes, Marseille, France.

Sami Fakhfakh (S)

Department of Oncologic Surgery 2, Institute Paoli Calmettes, Marseille, France.

Marion Picini (M)

Department of Care Coordination, Institute Paoli Calmettes, Marseille, France.

Maxime Tourret (M)

Department of Anesthesia and Intensive Care, Institute Paoli Calmettes, Marseille, France.

Clément Brun (C)

Department of Anesthesia and Intensive Care, Institute Paoli Calmettes, Marseille, France.

Gwenaelle Gravis (G)

Department of Medical Oncology, Institute Paoli Calmettes, Marseille, France.

Géraldine Pignot (G)

Department of Oncologic Surgery 2, Institute Paoli Calmettes, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH